1,796 material Form 8-K filings that 1,448 companies we cover made with the SEC in May 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ventas amended its at-the-market stock sale agreement, making $3.0 billion of common stock available for issuance, excluding shares sold before the amendment. That capacity could add shares outstanding, though the filing does not say any shares have been sold under it. At its May 13, 2026 annual meeting, shareholders elected all 12 director nominees, approved executive pay in an advisory vote, and ratified KPMG LLP as auditor for 2026.
Amendment No. 3, dated May 15, 2026, sets the aggregate gross sales price of common stock available under the sales agreement at $3,000,000,000.
At the May 13, 2026 annual meeting, 444,592,209 shares, or 93.50%, were represented.
Advisory say-on-pay vote: 392,256,709 votes for and 35,413,128 against; KPMG LLP ratified with 437,540,505 votes for.
Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, retired May 1, 2026; his separation agreement provides a prorated 2026 bonus based on target performance.
IDACORP entered into an equity distribution agreement on May 15, 2026, allowing it to sell up to $600 million of common stock from time to time, including shares tied to forward sale agreements. The company has no obligation to sell any shares, and it will not initially receive proceeds from borrowed shares sold by forward sellers.
Aggregate gross sale price of up to $600 million, including shares that may be sold under forward sale agreements.
Commission of up to 1.000% of sales price paid to each Manager, and up to 1.000% to each Forward Seller through a reduced forward sale price.
Proceeds from forward sales are expected only on physical settlement of seven Master Forward Sale Confirmations, each dated May 15, 2026.
Shares will be issued under an automatic shelf registration statement filed February 21, 2025 (File No. 333-285140) and a prospectus supplement dated May 15, 2026.
CenterPoint Energy entered into an Equity Distribution Agreement on May 15, 2026, allowing it to sell up to $1 billion of common stock through a group of managers and forward purchasers, with sales at its discretion through May 15, 2029. The agreement replaces a prior at-the-market program dated January 10, 2024, which had about $84.9 million unsold at termination, and it could add new shares outstanding, which would dilute existing shareholders.
Equity Distribution Agreement dated May 15, 2026 covers up to $1,000,000,000 in common stock sales, including through forward sale agreements.
Managers and forward sellers receive commissions of up to 1% of gross sales prices.
Prior at-the-market program dated January 10, 2024, was terminated with about $84.9 million unsold.
Net proceeds are expected to fund general corporate purposes, including capital expenditures and repayment of commercial paper borrowings; the company has no obligation to sell any shares.
Hubbell entered a Term Loan Agreement on May 15, 2026, allowing it to borrow up to $900 million on an unsecured basis. The proceeds are to finance the NSI Acquisition, repay certain existing NSI debt, and cover related fees and expenses. The loan adds debt for shareholders to weigh, and funding depends on the NSI Acquisition closing.
Borrowing capacity of up to $900 million, available in a single draw on the NSI Acquisition closing date
Loans are due on the third anniversary of the borrowing date and bear interest at Alternate Base Rate or Term SOFR plus a margin based on Hubbell's credit ratings
Financial covenant requires total indebtedness to total capitalization of no more than 65% at each fiscal quarter-end
Default triggers include other debt acceleration above $100 million and a change of control of Hubbell
Novanta entered into a Second Amendment to its Fourth Amended and Restated Credit Agreement with Bank of America, N.A. as administrative agent. The amendment establishes $200.0 million of delayed draw term loan commitments that the company can borrow against for up to six months, with maturity on June 27, 2030. The filing gives no use of proceeds, so the effect on shareholders depends on whether and how the company draws the loans.
Second Amendment dated May 15, 2026 amends the credit agreement originally dated June 27, 2025
$200.0 million of delayed draw term loan commitments, available for up to six months after May 15, 2026
Loans mature June 27, 2030; interest is tied to the company's consolidated leverage ratio, with a commitment fee on undrawn amounts
Amortization begins on or around the last business day of the fiscal quarter ending September 25, 2026
Broadridge Financial Solutions closed its offering of $500 million of 5.750% senior notes, issued May 15, 2026 and maturing May 15, 2036. The company plans to use the net proceeds, together with cash on hand, to repay its outstanding 3.400% senior notes due 2026, so the filing mainly reflects a refinancing that adds long-term debt.
$500 million aggregate principal of 5.750% senior notes issued May 15, 2026, maturing May 15, 2036
Interest payable in cash on May 15 and November 15 each year, beginning November 15, 2026
Net proceeds plus cash on hand to be used to repay the 3.400% senior notes due 2026
Notes are unsecured, not guaranteed by subsidiaries, and carry a 101% change-of-control repurchase offer
Cerebras Systems Inc. completed its initial public offering of Class A common stock on May 15, 2026, selling 34,500,000 shares at $185.00 per share, including the underwriters' full option of 4,500,000 additional shares. The company also adopted amended and restated charter and bylaws that took effect at the IPO closing, which shareholders can review in the filing's exhibits and in the prospectus.
IPO priced at $185.00 per share; 34,500,000 shares sold, including 4,500,000 from the underwriters' full option.
Gross proceeds to the company were $6.4 billion, before underwriting discounts and estimated offering expenses.
Amended and restated certificate of incorporation was filed with Delaware on May 15, 2026; bylaws took effect at closing.
Final prospectus is dated May 13, 2026; the registration statement on Form S-1 was filed May 14, 2026.
On May 15, 2026, BGC Group entered into a Third Amended and Restated Credit Agreement with Bank of America, N.A. as administrative agent, providing a $700 million unsecured revolving credit facility that can be increased to $900 million and extends maturity to May 15, 2030. The filing says $240 million of existing borrowings remain outstanding under the new facility, and the company plans to use borrowings for general corporate purposes.
Facility size: $700 million unsecured revolver, expandable to $900 million subject to conditions
Maturity extended to May 15, 2030
Initial margin of 1.875% over Term SOFR; Term SOFR-based rate would have been about 5.48% at May 15, 2026 close
Covenants on net worth and net excess capital raised; $240 million of borrowings carried over
AMD entered a new five-year, $5.0 billion unsecured revolving credit facility with JPMorgan Chase Bank as administrative agent, replacing its existing facility, and it raised the cap on its commercial paper program to $5.5 billion from $3.0 billion. No borrowings were outstanding under the revolving facility at signing. Stockholders also approved an equity plan increase of 65 million shares at the May 13 annual meeting.
Five-year, $5.0 billion unsecured revolving credit facility dated May 14, 2026, with no borrowings outstanding at signing
Commercial paper program maximum raised to $5.5 billion from $3.0 billion; notes may mature in up to 397 days
Stockholders approved a 65 million share increase to the 2023 Equity Incentive Plan, bringing the total to 153 million shares
Shareholder proposal to lower the ownership threshold for calling a special meeting was not approved, with 624 million votes against
ServiceNow completed a $4 billion offering of senior notes in five tranches maturing between 2028 and 2056, issued under an existing shelf registration. The filing adds debt of that size to the company's obligations, and it does not state how the proceeds will be used.
Five tranches: $750 million due 2028 at 4.250%, $600 million due 2031 at 4.700%, $650 million due 2033 at 5.050%, $1.25 billion due 2036 at 5.400%, and $750 million due 2056 at 6.300%
Underwriting Agreement dated May 12, 2026 with Barclays Capital, Citigroup Global Markets, J.P. Morgan Securities and Wells Fargo Securities as representatives
Indenture with U.S. Bank Trust Company, National Association, as trustee, dated May 15, 2026
Skadden, Arps, Slate, Meagher & Flom LLP issued a legality opinion on the notes
Starlink AI Acquisition Corporation, a blank check company, closed its initial public offering of 10,000,000 units at $10.00 per unit on May 11, 2026, generating gross proceeds of $100,000,000. The company placed $100,500,000 in a U.S.-based trust account and filed an audited May 11, 2026 balance sheet, which shows a going concern doubt tied to its 12-month deadline to complete a business combination.
IPO of 10,000,000 units at $10.00 per unit, gross proceeds of $100,000,000, closed May 11, 2026
Private placement of 221,500 units to sponsor JKapital Ltd. for $2,215,000
$100,500,000 ($10.05 per public unit) placed in trust account with Continental Stock Transfer & Trust Company as trustee
Auditor expresses substantial doubt about going concern; company has until May 11, 2027 to complete a business combination
Encompass Health priced a private offering of $500 million of 5.875% senior notes due 2034 at 100% of principal, with closing expected on or about May 29, 2026. The company plans to use the proceeds, together with cash on hand, to redeem $400 million of its 4.500% notes due 2028 at par and to repay $100 million under its revolving credit facility, which changes the mix of its debt but the filing does not state a figure for the effect on interest expense.
$500 million principal of 5.875% senior notes due 2034 priced at 100% of principal, announced May 14, 2026
Expected closing on or about May 29, 2026, subject to customary conditions; interest paid semiannually on June 1 and Dec. 1, starting Dec. 1, 2026
Proceeds plus cash on hand: $400 million to redeem 4.500% notes due 2028 (of $800 million outstanding) and $100 million to repay revolver borrowings
SLM Corporation closed a $500 million offering of 6.495% fixed-to-floating rate senior notes maturing May 15, 2032. The company said it will use the proceeds to fund a tender offer for its 3.125% senior notes due 2026, with any remaining proceeds used to repay those 2026 notes at maturity.
Notes total $500 million, close date May 15, 2026, maturing May 15, 2032
Fixed rate of 6.495% through May 15, 2031, then floating at Benchmark plus 271 basis points
Proceeds to fund tender offer for 3.125% senior notes due 2026, with remainder for repayment at maturity
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.